YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

Millions of users work with SQL to keep the gears of their business turning. In an era marked by relentless digital transformation, the proliferation of AI workloads, and tightening regulatory demands ...

Fintel reports that on October 10, 2025, Needham reiterated coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 4.31% Upside As of September 30, 2025, the ...

YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode Ltd. (NASDAQ:INMD) Q2 2025 Earnings Call Transcript July 30, 2025 InMode Ltd. beats earnings expectations. Reported EPS is $0.47, expectations were $0.43. Operator: Good day, and welcome to ...

We’re excited to announce a new migration capability in Azure Arc to simplify and accelerate SQL Server migration. This new capability, now generally available, is powered by Azure Database Migration ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...